IMMX
Immix Biopharma Inc
11.90$
-7.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.23 | -0.05 | -0.43 | -0.53 | -0.66 | -0.52 | -0.73 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| – | 0.00 | 0.06 | 0.04 | 0.15 | 0.11 | 0.07 | |
| 0.17 | 0.07 | 6.30 | 0.04 | – | – | – | |
| 0.05 | 0.02 | -0.11 | 0.01 | 0.10 | 0.14 | 0.08 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | |
| 0.00 | 0.00 | 0.00 | – | 0.00 | -0.04 | -0.22 | |
| – | – | 0.00 | -0.01 | 0.00 | – | – | |
| 0.31 | 0.03 | 0.05 | 0.00 | 0.00 | – | – | |
| 0.31 | 2.42 | 5.13 | 0.23 | 0.89 | 0.56 | 3.26 | |
| 0.08 | -0.04 | 4.70 | -0.30 | 0.23 | 0.01 | 2.31 | |
| -0.24 | -0.05 | -0.43 | -0.53 | -0.66 | -0.56 | -0.75 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.